Is Foghorn Therapeutics Inc. (FHTX) a Buy, Sell, or Hold?
Foghorn Therapeutics Inc.
NASDAQ:FHTX
$5.45 USD
$0.07 (1.3%)
- Volume
- 246.55K
- Average Volume
- 226.27K
- Market Capitalization
- $319.99M
- P/E Ratio
- -4.66
- Dividend Yield
- 0.00%
- Price Target
- $12.00
- Year High
- $6.95
- Year Low
- $3.27
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.92
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
32
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
4
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 604.61K
FHTX Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
FHTX Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Lynch Thomas J. Jr. | director | 2026-06-24 | A-Award | 4.08 | 2026-06-25 |
| Duty Stuart | director | 2026-06-24 | A-Award | 4.08 | 2026-06-25 |
| Biller Scott | director | 2026-06-24 | A-Award | 4.08 | 2026-06-25 |
| Gallagher Neil | director | 2026-06-24 | A-Award | 4.08 | 2026-06-25 |
| Mendelsohn Michael | director | 2026-06-24 | A-Award | 4.08 | 2026-06-25 |
| SMITH IAN F | director | 2026-06-24 | A-Award | 4.08 | 2026-06-25 |
| GILL SIMBA | director | 2026-06-24 | A-Award | 4.08 | 2026-06-25 |
| PARSHALL B LYNNE | director | 2026-06-24 | A-Award | 4.08 | 2026-06-25 |
| Cole Douglas G. | director | 2026-06-24 | A-Award | 4.08 | 2026-06-25 |
| GOTTSCHALK ADRIAN | director, officer: Chief Executive Officer | 2026-04-10 | G-Gift | 0 | 2026-04-13 |
| GOTTSCHALK ADRIAN | director, officer: Chief Executive Officer | 2026-04-10 | G-Gift | 0 | 2026-04-13 |
| GOTTSCHALK ADRIAN | director, officer: Chief Executive Officer | 2026-04-09 | G-Gift | 0 | 2026-04-13 |
| GOTTSCHALK ADRIAN | director, officer: Chief Executive Officer | 2026-04-09 | G-Gift | 0 | 2026-04-13 |
| Maynard Ryan D | officer: Chief Financial Officer | 2026-02-23 | A-Award | 5.75 | 2026-02-24 |
| Maynard Ryan D | 2026-02-23 | 0 | 2026-02-24 | ||
| GOTTSCHALK ADRIAN | director, officer: Chief Executive Officer | 2026-02-05 | A-Award | 5.23 | 2026-02-06 |
| Costa Carlos | officer: Chief People Officer | 2026-01-30 | A-Award | 5.71 | 2026-02-02 |
| LaCascia Michael | officer: Chief Legal Officer | 2026-01-30 | A-Award | 5.71 | 2026-02-02 |
| Cardama Alfonso Quintas | officer: Chief Medical Officer | 2026-01-30 | A-Award | 5.71 | 2026-02-02 |
| Rivkin Anna | officer: Chief Business Officer | 2026-01-30 | A-Award | 5.71 | 2026-02-02 |
| Bellon Steven F. | officer: Chief Scientific Officer | 2026-01-30 | A-Award | 5.71 | 2026-02-02 |
| Flagship Pioneering, LLC | director, 10 percent owner: | 2026-01-13 | A-Award | 0.0001 | 2026-01-15 |
| Flagship Pioneering, LLC | director, 10 percent owner: | 2026-01-13 | A-Award | 13.42 | 2026-01-15 |
| Flagship Pioneering, LLC | director, 10 percent owner: | 2026-01-13 | A-Award | 20.13 | 2026-01-15 |
| Humer Kristian | 2025-11-14 | 0 | 2025-11-17 | ||
| SMITH IAN F | director | 2025-06-17 | A-Award | 4.79 | 2025-06-17 |
| PARSHALL B LYNNE | director | 2025-06-17 | A-Award | 4.79 | 2025-06-17 |
| Mendelsohn Michael | director | 2025-06-17 | A-Award | 4.79 | 2025-06-17 |
| Lynch Thomas J. Jr. | director | 2025-06-17 | A-Award | 4.79 | 2025-06-17 |
| GILL SIMBA | director | 2025-06-17 | A-Award | 4.79 | 2025-06-17 |
| Biller Scott | director | 2025-06-17 | A-Award | 4.79 | 2025-06-17 |
| Cole Douglas G. | director | 2025-06-17 | A-Award | 4.79 | 2025-06-17 |
| Gallagher Neil | director | 2025-05-01 | A-Award | 4.16 | 2025-05-02 |
| Duty Stuart | director | 2025-05-01 | A-Award | 4.16 | 2025-05-02 |
| Gallagher Neil | 2025-05-01 | 0 | 2025-05-02 | ||
| Duty Stuart | 2025-05-01 | 0 | 2025-05-02 | ||
| GOTTSCHALK ADRIAN | director, officer: Chief Executive Officer | 2025-04-25 | G-Gift | 0 | 2025-04-28 |
| GOTTSCHALK ADRIAN | director, officer: Chief Executive Officer | 2025-04-25 | G-Gift | 0 | 2025-04-28 |
| GOTTSCHALK ADRIAN | director, officer: Chief Executive Officer | 2025-04-09 | G-Gift | 0 | 2025-04-10 |
| GOTTSCHALK ADRIAN | director, officer: Chief Executive Officer | 2025-04-09 | G-Gift | 0 | 2025-04-10 |
| Cardama Alfonso Quintas | officer: Chief Medical Officer | 2025-01-22 | A-Award | 4.37 | 2025-01-24 |
| Humer Kristian | officer: Chief Financial Officer | 2025-01-22 | A-Award | 4.37 | 2025-01-24 |
| Costa Carlos | officer: Chief People Officer | 2025-01-22 | A-Award | 4.37 | 2025-01-24 |
| Rivkin Anna | officer: Chief Business Officer | 2025-01-22 | A-Award | 4.37 | 2025-01-24 |
| GOTTSCHALK ADRIAN | director, officer: Chief Executive Officer | 2025-01-22 | A-Award | 4.37 | 2025-01-24 |
| Bellon Steven F. | officer: Chief Scientific Officer | 2025-01-22 | A-Award | 4.37 | 2025-01-24 |
| LaCascia Michael | officer: Chief Legal Officer | 2025-01-22 | A-Award | 4.37 | 2025-01-24 |
| Koppel Adam | 2024-12-29 | 0 | 2024-12-30 | ||
| Costa Carlos | officer: Chief People Officer | 2024-09-20 | M-Exempt | 3.72 | 2024-09-24 |
| Costa Carlos | officer: Chief People Officer | 2024-09-23 | M-Exempt | 3.72 | 2024-09-24 |
| Costa Carlos | officer: Chief People Officer | 2024-09-20 | M-Exempt | 3.72 | 2024-09-24 |
| Costa Carlos | officer: Chief People Officer | 2024-09-23 | M-Exempt | 3.72 | 2024-09-24 |
| Costa Carlos | officer: Chief People Officer | 2024-09-23 | S-Sale | 10.17 | 2024-09-24 |
| Costa Carlos | officer: Chief People Officer | 2024-09-20 | S-Sale | 10.04 | 2024-09-24 |
| Costa Carlos | officer: Chief People Officer | 2024-09-18 | M-Exempt | 3.72 | 2024-09-20 |
| Costa Carlos | officer: Chief People Officer | 2024-09-18 | M-Exempt | 3.72 | 2024-09-20 |
| Costa Carlos | officer: Chief People Officer | 2024-09-18 | S-Sale | 10.05 | 2024-09-20 |
| Costa Carlos | officer: Chief People Officer | 2024-09-16 | M-Exempt | 3.72 | 2024-09-18 |
| Costa Carlos | officer: Chief People Officer | 2024-09-17 | M-Exempt | 3.72 | 2024-09-18 |
| Costa Carlos | officer: Chief People Officer | 2024-09-17 | M-Exempt | 3.72 | 2024-09-18 |
| Costa Carlos | officer: Chief People Officer | 2024-09-16 | M-Exempt | 3.72 | 2024-09-18 |
| Costa Carlos | officer: Chief People Officer | 2024-09-17 | S-Sale | 10.04 | 2024-09-18 |
| Costa Carlos | officer: Chief People Officer | 2024-09-16 | S-Sale | 10 | 2024-09-18 |
| Bellon Steven F. | officer: Chief Scientific Officer | 2024-09-09 | S-Sale | 9.5 | 2024-09-11 |
| Rivkin Anna | officer: Chief Business Officer | 2024-09-03 | A-Award | 7.85 | 2024-09-04 |
| Rivkin Anna | 2024-09-03 | 0 | 2024-09-04 | ||
| Biller Scott | director | 2024-06-26 | A-Award | 5.52 | 2024-06-28 |
| Mendelsohn Michael | director | 2024-06-26 | A-Award | 5.52 | 2024-06-28 |
| SMITH IAN F | director | 2024-06-26 | A-Award | 5.52 | 2024-06-28 |
| Lynch Thomas J. Jr. | director | 2024-06-26 | A-Award | 5.52 | 2024-06-28 |
| GILL SIMBA | director | 2024-06-26 | A-Award | 5.52 | 2024-06-28 |
| Cole Douglas G. | director | 2024-06-26 | A-Award | 5.52 | 2024-06-28 |
| PARSHALL B LYNNE | director | 2024-06-26 | A-Award | 5.52 | 2024-06-28 |
| Koppel Adam | director | 2024-06-26 | A-Award | 5.52 | 2024-06-28 |
| Cavalie Fanny | 2024-06-21 | 0 | 2024-06-24 | ||
| Flagship Pioneering Inc. | 10 percent owner | 2024-05-22 | P-Purchase | 0.0001 | 2024-05-24 |
| Flagship Pioneering Inc. | 10 percent owner | 2024-05-22 | P-Purchase | 0.0001 | 2024-05-24 |
| Flagship Pioneering Fund VII General Partner LLC | 10 percent owner | 2024-05-22 | 0.0001 | 2024-05-24 | |
| Humer Kristian | officer: Chief Financial Officer | 2024-04-16 | A-Award | 6.03 | 2024-04-17 |
| Humer Kristian | 2024-04-16 | 0 | 2024-04-17 | ||
| Cavalie Fanny | officer: Chief Strategy/Bus Ops Officer | 2024-03-11 | S-Sale | 6.5576 | 2024-03-12 |
| GOTTSCHALK ADRIAN | director, officer: Chief Executive Officer | 2024-01-24 | A-Award | 3.06 | 2024-01-25 |
| Cardama Alfonso Quintas | officer: Chief Medical Officer | 2024-01-24 | A-Award | 3.06 | 2024-01-25 |
| Cavalie Fanny | officer: Chief Strategy/Bus Ops Officer | 2024-01-24 | A-Award | 3.06 | 2024-01-25 |
| Costa Carlos | officer: Chief People Officer | 2024-01-24 | A-Award | 3.06 | 2024-01-25 |
| Bellon Steven F. | officer: Chief Scientific Officer | 2024-01-24 | A-Award | 3.06 | 2024-01-25 |
| LaCascia Michael | officer: Chief Legal Officer | 2024-01-24 | A-Award | 3.06 | 2024-01-25 |
| Reine Allan | 2024-01-16 | 0 | 2024-01-17 | ||
| SMITH IAN F | director | 2023-12-08 | A-Award | 5.63 | 2023-12-12 |
| Agresta Samuel | 2023-09-11 | 0 | 2023-09-13 | ||
| Cardama Alfonso Quintas | officer: Chief Medical Officer | 2023-09-11 | A-Award | 7.57 | 2023-09-13 |
| Cardama Alfonso Quintas | 2023-09-11 | 0 | 2023-09-13 | ||
| Agresta Samuel | officer: Chief Medical Officer | 2023-08-16 | M-Exempt | 3.72 | 2023-08-18 |
| Agresta Samuel | officer: Chief Medical Officer | 2023-08-16 | M-Exempt | 3.72 | 2023-08-18 |
| Agresta Samuel | officer: Chief Medical Officer | 2023-08-16 | S-Sale | 8.25 | 2023-08-18 |
| GOTTSCHALK ADRIAN | director, officer: Chief Executive Officer | 2023-08-17 | G-Gift | 0 | 2023-08-18 |
| GOTTSCHALK ADRIAN | director, officer: Chief Executive Officer | 2023-08-17 | G-Gift | 0 | 2023-08-18 |
| PARSHALL B LYNNE | director | 2023-06-21 | A-Award | 8.7 | 2023-06-22 |
| Lynch Thomas J. Jr. | director | 2023-06-21 | A-Award | 8.7 | 2023-06-22 |
| Cole Douglas G. | director | 2023-06-21 | A-Award | 8.7 | 2023-06-22 |